Pharmaceutical Industry Information Portal

HomeTagsRidgeback Biotherapeutics

All posts by tag

Ridgeback Biotherapeutics

FDA Authorizes Use of Oral Antiviral Molnupiravir for Mild to Moderate COVID-19

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the U.S. Food and Drug Administration (FDA) has...

Expert Articles